| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| trifluoperazine | alpha-1a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Neoplasm Metastasis[MeSHID:D009362] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
0.13 | approved,investigational | antagonist |
| trifluoperazine | calmodulin | small molecule | NA | drugbank | Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Neoplasm Metastasis[MeSHID:D009362] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
NA | approved,investigational | inhibitor |
| trifluoperazine | neuron-specific vesicular protein calcyon | small molecule | NA | drugbank , DGIDB | Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Neoplasm Metastasis[MeSHID:D009362] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
5.68 | approved,investigational | antagonist |
| trifluoperazine | dopamine d2 receptor | small molecule | NA | drugbank , DGIDB | Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Neoplasm Metastasis[MeSHID:D009362] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
0.12 | approved,investigational | antagonist |
| trifluoperazine | protein s100-a4 | small molecule | NA | drugbank | Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Neoplasm Metastasis[MeSHID:D009362] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
NA | approved,investigational | inhibitor |
| trifluoperazine | troponin c, slow skeletal and cardiac muscles | small molecule | NA | drugbank | Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Neoplasm Metastasis[MeSHID:D009362] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
NA | approved,investigational | unknown |
| click here to return to the previous page | ||||||||